By Kamal Choudhury Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain ...

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants.

This is the second in a series of discussions with Mike Glass, owner of Orion Technical Solutions, on ensuring data integrity ...

Levine Leichtman Capital Partners has agreed to acquire USA Industries, a Houston-based manufacturer of industrial flow control and testing products, from Sky Island Capital. USA Industries’ products ...

The power surging through transmission lines over the iconic stone walls of England’s northern countryside is pushing the ...

The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...

In a first, the US FDA has approved a device that allows you to treat depression at home. The headset delivers a mild ...

FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat ...

The US Food and Drug Administration has approved the first at-home brain-stimulation device for treating depression.

Play big on a small screen with the ROG Flow Z13 running SteamOS 3.9, a 13-inch 180 Hz panel that brings smoother action ...

The executive order comes as the president has signed off on unprecedented airstrikes on suspected drug-carrying boats in the ...